FDA Hosting Companion Diagnostics Workshop

The FDA, in collaboration with the American Association for Cancer Research and the American Society of Clinical Oncology, will hold a March 24 public workshop in Washington, D.C., on the challenges of harmonizing companion diagnostics across a class of targeted therapies. The aim is to foster collaborations in the clinical cancer research community and provide a deeper understanding of issues surrounding the development of anticancer drug and devices.

Registration is free and available on a first-come, first-serve basis. Those interested must register online by March 17. The agency is also soliciting electronic or written comments on all aspects of the public workshop by April 23.

To read the meeting notice, go to www.fdanews.com/03-09-15-PublicWorkshop.pdf. — Kellen Owings